Cannabis Bioscience International Holdings, Inc. reported earnings results for the first quarter ended August 31, 2023. For the first quarter, the company reported sales was USD 0.072821 million compared to USD 0.143752 million a year ago. Net loss was USD 0.181789 million compared to USD 0.162375 million a year ago.

Basic loss per share from continuing operations was USD 0.00002 compared to USD 0.00002 a year ago.